Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma

British Journal of Cancer

Volumn 102, Issue 5, 2010, Pages 867-872

  Jeppesen, A N ^a   Jensen, H K ^a   Donskov, F ^a   Marcussen, N ^b   Von Der Maase, H ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Metastatic; Mortality; Predictive; Renal cell carcinoma; Sodium

Indexed keywords

DENDRITIC CELL VACCINE; INTERLEUKIN 21; LACTATE DEHYDROGENASE; LAPATINIB; MEDROXYPROGESTERONE; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT INTERLEUKIN 2; SODIUM; SORAFENIB; SUNITINIB;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPONATREMIA; KIDNEY CARCINOMA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SODIUM BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPONATREMIA; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SODIUM; SURVIVAL RATE; YOUNG ADULT;

EID: 77649269726     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605563     Document Type: Article

References (30)

1. Asadollahi K, Hastings IM, Beeching NJ, Gill GV (2007) Laboratory risk factors for hospital mortality in acutely admitted patients. QJM 100: 501-507
2. Bahrami A, Truong LD, Shen SS, Krishnan B (2009) Synchronous renal and adrenal masses: an analysis of 80 cases. Ann Diagn Pathol 13: 9-15
3. Chao YN, Chiu NC, Huang FY (2008) Clinical features and prognostic factors in childhood pneumococcal meningitis. J Microbiol Immunol Infect 41: 48-53
4. Choueiri TK (2009) Prognostic factors in metastatic renal cell carcinoma. In Renal Cell Carcinoma, Rini BI, Campbell SC (eds) pp 154-166
5. People's medical publishing house: Shelton, Connecticut Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353: 2477-2490
6. Donskov F, von der Maase H (2006) Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol 24: 1997-2005
7. Gandhi L, Johnson BE (2006) Paraneoplastic syndromes associated with small cell lung cancer. J Natl Compr Canc Netw 4: 631-638
8. Ghali JK (2008) Mechanisms, risks, and new treatment options for hyponatremia. Cardiology 111: 147-157
9. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Pina IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O'Connor CM (2007) Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 167: 1998-2005
10. Gotsman I, Zwas D, Planer D, Azaz-Livshits T, Admon D, Lotan C, Keren A (2008) Clinical outcome of patients with heart failure and preserved left ventricular function. Am J Med 121: 997-1001
11. Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD (2008) The MELD-Na is an independent short-and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Dig Liver Dis 40: 882-889
12. Kacprowicz RF, Lloyd JD (2009) Electrolyte complications of malignancy. Emerg Med Clin North Am 27: 257-269
13. Kim HS, Yi SY, Jun HJ, Lee J, Park JO, Park YS, Jang J, Kim HJ, Ko Y, Lim HY, Kang WK (2007) Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology 73: 192-197
14. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM (2008) Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359: 1018-1026
15. Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J (2007) An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 13: 1174-1180
16. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207-214
17. Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M (2002) Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 20: 289-296
18. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17: 2530-2540
19. Nair V, Niederman MS, Masani N, Fishbane S (2007) Hyponatremia in community-acquired pneumonia. Am J Nephrol 27: 184-190
20. Palmer SM, Kaufman RA, Salamone SJ, Blake-Court J, Bette W, Wahl HP, Furrer F (1995) Cobas Integra: clinical laboratory instrument with continuous and random-access capabilities. Clin Chem 41: 1751-1760
21. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
22. Patel GP, Balk RA (2007) Recognition and treatment of hyponatremia in acutely ill hospitalized patients. Clin Ther 29: 211-229
23. Redondo FL, Bermudez P, Cocco C, Colella F, Graziani MS, Fiehn W, Hierla T, Lemoel G, Belliard A, Manene D, Meziani M, Liebel M, McQueen MJ, Stockmann W (2003) Evaluation of Cobas Integra 800 under simulated routine conditions in six laboratories. Clin Chem Lab Med 41: 365-381
24. Rossi J, Bayram M, Udelson JE, Lloyd-Jones D, Adams KF, Oconnor CM, Stough WG, Ouyang J, Shin DD, Orlandi C, Gheorghiade M (2007) Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care 9: 82-86
25. Rusinaru D, Buiciuc O, Leborgne L, Slama M, Massy Z, Tribouilloy C (2009) Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction. Am J Cardiol 103: 405-410
26. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K (1997) Classification of renal cell carcinoma: Workgroup No 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 987-989
27. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216
28. Vasudev NS, Brown JE, Brown SR, Rafiq R, Morgan R, Patel PM, O'Donnell D, Harnden P, Rogers M, Cocks K, Anderson K, Paul A, Eardley I, Selby PJ, Banks RE (2008) Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival. Clin Cancer Res 14: 1775-1781
29. Yaghoubian A, de Virgilio C, Dauphine C, Lewis RJ, Lin M (2007) Use of admission serum lactate and sodium levels to predict mortality in necrotizing soft-tissue infections. Arch Surg 142: 840-846
30. Yokoyama H, Tanaka M (2005) Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy? BJU Int 95: 526-529